100 Clinical Results associated with NT Pharma International Co., Ltd.
0 Patents (Medical) associated with NT Pharma International Co., Ltd.
HK-listed pharmaceutical company China NT Pharma Group Company Limited has entered into an agreement to acquire a 40 per cent stake in Beijing Konruns Pharmaceutical’s unit Kangchen for 360 million yuan ($51 million) in a bid to reshuffle its business.
100 Deals associated with NT Pharma International Co., Ltd.
100 Translational Medicine associated with NT Pharma International Co., Ltd.